Search Results

You searched for : lilly  

FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly

As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need ...
Nov 17

A Ray of Hope in Alzheimer's Research: Donanemab Shows Promise in Slowing Cognitive Decline

The findings not only represent a major breakthrough for Eli Lilly but also for the scientific community as a whole, proving that perseverance and dedication ...
Jul 18

AbCellera-Discovered Antibody, Bebtelovimab, receives FDA Emergency Use Authorization for the treatment COVID-19

Treatment of mild and moderate Covid19 ...
Feb 14

US FDA approves Jardiance (empagliflozin) to treat adults living with heart failure with reduced ejection fraction

Latest Pharma News Update...
Aug 23

Lilly Announces Acquisition of Protomer Technologies

Pharma merger and acquisitions...
Jul 15

Alzheimer's Disease Fast Facts

Facts about the Alzheimer's disease...
Jul 08

Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Final Approval for Testosterone Topical Solution USP, 30 mg per pump actuation

Testosterone Topical Solution USP, 30 mg per pump actuation is indicated for replacement therapy in males for conditions associated with a deficiency or absence of ...
Jun 17

Eli Lilly and MiNA Therapeutics Announce saRNA Research Collaboration

MiNA will utilize its saRNA platform to research up to five targets selected by Lilly that aim to address diseases across Lilly's key therapeutic ...
May 15

US government stops distribution of Eli Lilly Covid-19 antibody treatment for Covid-19

The move comes after the detection of different Covid variants ...
Mar 26

Lilly and Rigel enter strategic collaboration to develop RIPK1 Inhibitors

The inhibitor is for the potential treatment of Immunological and Neurodegenerative diseases...
Feb 22

Glenmark receives ANDA final approval for Tadalafil Tablets

Glenmark has also received tentative approval by the U.S. FDA for Gabapentin Enacarbil Extended-Release Tablets, the generic version of Horizant 1of Arbor Pharmaceuticals....
Dec 31

Eli Lilly announces agreement to acquire Prevail Therapeutics

The acquisition will establish a new modality for drug discovery and development at Lilly ...
Dec 15

AbCellera-discovered antibody granted interim authorization by health Canada as a treatment for COVID-19

Bamlanivimab received emergency use authorization (EUA) from the U.S. Food and Drug Administration on November 9, 2020...
Nov 23

Eli Lilly collaborates with Precision BioSciences for genome editing research

This collaboration will help to accelerate the work aimed to solve genetic diseases with unique editing challenges...
Nov 21

Empagliflozin reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME trial

...
Nov 19

Eli Lilly's bamlanivimab receives US FDA clearance for the treatment of COVID-19

Eli Lilly’s neutralizing antibody bamlanivimab receives US FDA emergency use authorization for the treatment of recently diagnosed COVID-19...
Nov 12

WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir

WHO-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but shunning Gilead's GILD....
Nov 06

Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric cancer

Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric ...
Oct 28

Lilly hires outside advisor for COVID drug plant problems

The company reiterated that it had not received a warning letter from the U.S. Food and Drugs Administration following inspections at the plant....
Oct 21

Gilead questions WHO study that cast doubts on drug's COVID-19 benefits

The antiviral medication was one of the drugs used to treat U.S. President Donald Trump’s coronavirus infection, and has been shown in previous ...
Oct 16

Eli Lilly announces agreement to acquire Disarm Therapeutics

Eli Lilly successfully develop and commercialize new medicines resulting from the acquisition...
Oct 16

J & J and Eli Lilly halts Covid-19 drug trial

ELI Lilly, J & J and AstraZeneca halts covid drug trials...
Oct 15

Innovent and Eli Lilly announce the NMPA granted marketing approval for HALPRYZA in China

The survival rate is also relatively higher than other tumour types when having appropriate treatment...
Oct 09

Verzinio from Eli Lilly cuts recurrence from Breast Cancer by 25%

Drug combo cuts recurrence risk of breast cancer by 25%...
Sep 21

Good immunity is always better then vaccine : Experts

The coronavirus, SARS-CoV-2, is the latest in a procession of new infectious diseases that have surprised the world in recent years...
Sep 15

25 Matching result(s) found!

-Advertisements-




Trending Now

Surviving Against the Odds: Steven Spinale's Journey After an Ingrown Hair Turns DeadlyMarch 29, 2024
10 reasons why media research and Planning are essential in Healthcare marketingMarch 29, 2024
The Surprising Link Between Sleep and Age Perception: What You Need to KnowMarch 29, 2024
The Dark Side of Beauty: Kidney Damage from Hair Straightening TreatmentsMarch 29, 2024
The Dark Side of Beauty: Kidney Damage from Hair Straightening TreatmentsMarch 29, 2024
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 StudyMarch 29, 2024
Sexual wellness superstore, Love Depot launches digital campaign to deliver every desireMarch 28, 2024
Recharge Your Life: Simple Ways to Boost Your Physical and Mental EnergyMarch 28, 2024
The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024